Mackenzie Financial’s NantHealth, Inc NH Stock Holding History

Mackenzie Financial’s Portfolio NH Stock Details NH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-753	Closed	-$26K	–	1107
2020 Q3	$26K	Buy	+753	New	+$42.5K	﹤0.01%	980

Other funds holding NH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Mackenzie Financial's NH Position: Q4 2020 in Review

Mackenzie Financial sold out of NantHealth, Inc (NH) in Q4 2020, closing a stake of 753 shares — an estimated $26K sold.

Mackenzie Financial first reported a position in NH in Q3 2020 and held it in 1 quarter. The position peaked at $26K in Q3 2020. 49 funds tracked by Wall St. Rank hold NH as of Q4 2020.

Mackenzie Financial reported no remaining NantHealth, Inc position as of Q4 2020 after selling out during the quarter.
Mackenzie Financial sold 753 NantHealth, Inc shares in Q4 2020, an estimated $26K.
Mackenzie Financial first reported a position in NantHealth, Inc in Q3 2020 and held it in 1 quarter.
Mackenzie Financial's NantHealth, Inc position peaked at $26K in Q3 2020.
49 funds tracked by Wall St. Rank held NantHealth, Inc as of Q4 2020.

Based on Mackenzie Financial's 13F filing for Q4 2020, filed 10 Feb 2021.